Terms: = Pancreatic cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Treatment
18 results:
1. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for treatment of pancreatic cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor.
Chen C; Park AK; Monroy I; Ren Y; Kim SI; Chaurasiya S; Priceman SJ; Fong Y
J Am Coll Surg; 2024 Apr; 238(4):436-447. PubMed ID: 38214445
[TBL] [Abstract] [Full Text] [Related]
2. [Exocrine pancreatic cancer - what is new in the update of the S3 guideline?].
Seufferlein T; Kestler A
Dtsch Med Wochenschr; 2023 Jun; 148(12):737-743. PubMed ID: 37257475
[TBL] [Abstract] [Full Text] [Related]
3. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer.
Graus MUJE; de Hingh IHJT; Besselink MG; Bruno MJ; Wilmink JW; de Meijer VE; van Velthuysen MF; Valkenburg-van Iersel LBJ; van der Geest LGM; de Vos-Geelen J; ; ;
HPB (Oxford); 2023 Oct; 25(10):1195-1202. PubMed ID: 37236831
[TBL] [Abstract] [Full Text] [Related]
4. Validation of a Resectability Scoring System for Prediction of pancreatic Adenocarcinoma Surgical Outcomes.
Toesca DAS; Susko M; von Eyben R; Baclay JRM; Pollom EL; Jeffrey RB; Poullos PD; Poultsides GA; Fisher GA; Visser BC; Koong AC; Feng M; Chang DT
Ann Surg Oncol; 2023 Jun; 30(6):3479-3488. PubMed ID: 36792768
[TBL] [Abstract] [Full Text] [Related]
5. Role of N
Ye T; Wang J; Zhao H; Zhao G; Li P
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36367195
[TBL] [Abstract] [Full Text] [Related]
6. Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values.
Amin S; Joo S; Nolte S; Yoo HK; Patel N; Byrnes HF; Costa-Cabral S; Johnson CD
BMC Cancer; 2022 May; 22(1):563. PubMed ID: 35596182
[TBL] [Abstract] [Full Text] [Related]
7. [treatment of severe post-resection liver failure. Analysis of the specialized center].
Alikhanov RB; Efanov MG; Subbotin VV; Novikova EV; Shchadrina KV; Buldakov MY
Khirurgiia (Mosk); 2020; (12):88-92. PubMed ID: 33301260
[TBL] [Abstract] [Full Text] [Related]
8. Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective cancer-VTE Registry.
Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Oba MS; Kimura T; Ibusuki K; Sakon M
Jpn J Clin Oncol; 2020 Oct; 50(11):1246-1253. PubMed ID: 32715307
[TBL] [Abstract] [Full Text] [Related]
9. Folfirinox chemotherapy prolongs stent patency in patients with malignant biliary obstruction due to unresectable pancreatic cancer.
Kang J; Lee SH; Choi JH; Paik WH; Ahn DW; Jeong JB; Ryu JK; Kim YT
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):590-595. PubMed ID: 32532598
[TBL] [Abstract] [Full Text] [Related]
10. pancreatic resections are not only safest but also most cost-effective when performed in a high-volume centre: A Finnish register study.
Ahola R; Sand J; Laukkarinen J
Pancreatology; 2019 Jul; 19(5):769-774. PubMed ID: 31239104
[TBL] [Abstract] [Full Text] [Related]
11. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study.
Kim JS; Kang EJ; Kim DS; Choi YJ; Lee SY; Kim HJ; Seo HY; Kim JS
BMC Cancer; 2018 Dec; 18(1):1260. PubMed ID: 30558603
[TBL] [Abstract] [Full Text] [Related]
12. Strategy for discriminating cholesterol and premalignancy in polypoid lesions of the gallbladder: a single-centre, retrospective cohort study.
Wu T; Sun Z; Jiang Y; Yu J; Chang C; Dong X; Yan S
ANZ J Surg; 2019 Apr; 89(4):388-392. PubMed ID: 30497105
[TBL] [Abstract] [Full Text] [Related]
13. Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis.
Xu LL; Zhang M; Yi PS; Zheng XB; Feng L; Lan C; Tang JW; Ren SS; Xu MQ
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):974-980. PubMed ID: 29270762
[TBL] [Abstract] [Full Text] [Related]
14. Impact of diabetes mellitus on the outcome of pancreatic cancer.
Beg MS; Dwivedi AK; Ahmad SA; Ali S; Olowokure O
PLoS One; 2014; 9(5):e98511. PubMed ID: 24879130
[TBL] [Abstract] [Full Text] [Related]
15. Perioperative immunonutrition in surgical cancer patients: a summary of a decade of research.
Klek S; Szybinski P; Szczepanek K
World J Surg; 2014 Apr; 38(4):803-12. PubMed ID: 24178185
[TBL] [Abstract] [Full Text] [Related]
16. Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.
Binder D; Hübner RH; Temmesfeld-Wollbrück B; Schlattmann P
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1575-83. PubMed ID: 21547571
[TBL] [Abstract] [Full Text] [Related]
17. Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer.
Danese MD; Reyes C; Northridge K; Lubeck D; Lin CY; O'Connor P
Clin Ther; 2008 Apr; 30(4):775-84. PubMed ID: 18498925
[TBL] [Abstract] [Full Text] [Related]
18. [Palliative treatment by endoprosthesis of icterus caused by distal biliary tumoral obstruction].
Buffet C; Couderc T; Fritsch J; Choury A; Lefebvre JF; Marteau V; Ink O; Bonnel D; Liguory C; Etienne JP
Gastroenterol Clin Biol; 1993; 17(10):629-35. PubMed ID: 7507069
[TBL] [Abstract] [Full Text] [Related]
